RAP2C has been found to be an important molecular switch in the mitogen-activated protein kinase (MAPK) signaling pathway in breast cancer; RAP2C reduces apoptosis and promotes proliferation and migration through the MAPK signaling pathway (Zhu et al., 2020). Here, WNK2 is linked to breast cancer.